Nektar Therapeutics Free Cash Flow Generation Index

Latest as of June 2018: 1.00x

Nektar Therapeutics free cash flow generation index. Nektar Therapeutics (NKTR) has a Free Cash Flow Generation Index of 1.00x as of June 2018. Free cash flow of $956.90 Million represents 1% of operating cash flow ($959.64 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$956.90 Million
USD

Operating Cash Flow

$959.64 Million
USD

Capital Expenditures

$2.75 Million
USD

Free Cash Flow Generation Index of Nektar Therapeutics (1997–2018)

Free cash flow generation index of Nektar Therapeutics from 1997 to 2018. Historical FCF Generation Index trend for Nektar Therapeutics across 4 annual periods. See how financially flexible is Nektar Therapeutics to measure the company's free cash flow as a share of total liabilities.

Nektar Therapeutics Free Cash Flow Generation Index by Year (1997–2018)

Nektar Therapeutics free cash flow generation index by year from 1997 to 2018. Year-by-year Free Cash Flow Generation Index for Nektar Therapeutics. For the full cash flow conversion analysis, see cash efficiency ratio of Nektar Therapeutics.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2018 0.98x $703.98 Million $718.21 Million $14.24 Million ▲ +104.6%
2009 0.48x $19.04 Million $39.74 Million $20.70 Million ▼ -38.3%
2007 0.78x $113.51 Million $146.30 Million $32.80 Million ▲ +131.5%
1997 -2.47x $-12.28 Million $4.98 Million $17.26 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).